Structural glycobiology: Applications in organ transplantation

Structural Glycobiology

Volumn , Issue , 2012, Pages 215-234

  Christiansen, Dale ^a   Agostino, Mark ^b   Yuriev, Elizabeth ^b   Ramsland, Paul A ^a,b,c   Sandrin, Mauro S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873715484     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12965     Document Type: Chapter

References (123)

1. Agostino, M., Jene, C., Boyle, T., Ramsland, P. A., and Yuriev, E. 2009. Molecular docking of carbohydrate ligands to antibodies: Structural validation against crystal structures. J Chem Inf Model, 49, 2749-2760.
2. Agostino, M., Sandrin, M. S., Thompson, P. E., Yuriev, E., and Ramsland, P. A. 2009. In silico analysis of antibody-carbohydrate interactions and its application to xenoreactive antibodies. Mol Immunol, 47, 233-246.
3. Agostino, M., Sandrin, M. S., Thompson, P. E., Yuriev, E., and Ramsland, P. A. 2010. Identification of preferred carbohydrate binding modes in xenoreactive antibodies by combining conformational filters and binding site maps. Glycobiology, 20, 724-735.
4. Ashford, D. A., Alafi, C. D., Gamble, V. M. et al. 1993. Site-specific glycosylation of recombinant rat and human soluble CD4 variants expressed in Chinese hamster ovary cells. J Biol Chem, 268, 3260-3267.
5. Boix, E., Swaminathan, G. J., Zhang, Y. et al. 2001. Structure of UDP complex of UDP-galactose: beta-galactoside-alpha -1,3-galactosyltransferase at 1.53-A resolution reveals a conformational change in the catalytically important C terminus. J Biol Chem, 276, 48608-48614.
6. Borrebaeck, C. K., Malmborg, A. C., and Ohlin, M. 1993. Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics? Immunol Today, 14, 477-479.
7. Bos, N. A., Kimura, H., Meeuwsen, C. G. et al. 1989. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol, 19, 2335-2339.
8. Brigl, M., van den Elzen, P., Chen, X. et al. 2006. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol, 176, 3625-3634.
9. Ceroni, A., Dell, A., and Haslam, S.M. 2007. The GlycanBuilder: A fast, intuitive and flexible software tool for building and displaying glycan structures. Source Code Biol Med, 2, 3.
10. Chen, G., Qian, H., Starzl, T. et al. 2005. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med, 11, 1295-1298.
11. Cheng, L., Ueno, A., Cho, S. et al. 2007. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition. J Immunol, 178, 2755-2762.
12. Chester, M. A. and Olsson, M. L. 2001. The ABO blood group gene: A locus of considerable genetic diversity. Transfus Med Rev, 15, 177-200.
13. Chong, A., Blinder, L., Ma, L. et al. 2000. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol, 8, 129-137.
14. Christiansen, D., Milland, J., Mouhtouris, E. et al. 2008. Humans lack iGb3 due to the absence of functional iGb3-synthase: Implications for NKT cell development and transplantation. PLoS Biol, 6, e172.
15. Christiansen, D., Vaughan, H. A., Miland, J. et al. 2011. Antibody responses to glycolipid borne carbohydrates require CD4+ T cells but not CD1 or NKT cells. Immunol Cell Biol, 89, 502-510.
16. Chung, C. H., Mirakhur, B., Chan, E. et al. 2008. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med, 358, 1109-1117.
17. Commins, S. P., James, H. R., Kelly, L. A. et al. 2011. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose. J Allergy Clin Immunol, 127, 1286-1293.
18. Commins, S. P., Satinover, S. M., Hosen, J. et al. 2009. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol, 123, 426-433.
19. Cooper, D. K., Good, A. H., Koren, E. et al. 1993. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man. Transpl Immunol, 1, 198-205.
20. Cooper, D. K., Koren, E., and Oriol, R. 1994. Oligosaccharides and discordant xenotransplantation. Immunol Rev, 141, 31-58.
21. Cramer, D. V. 2000. Natural antibodies and the host immune responses to xenografts. Xenotransplantation, 7, 83-92.
22. Cretin, N., Bracy, J., Hanson, K., and Iacomini, J. 2002. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal. J Immunol, 168, 1479-1483.
23. Dai, Y., Vaught, T. D., Boone, J. et al. 2002. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol, 20, 251-255.
24. Diswall, M., Angstrom, J., Schuurman, H. J. et al. 2007. Studies on glycolipid antigens in small intestine and pancreas from alpha1,3-galactosyltransferase knockout miniature swine. Transplantation, 84, 1348-1356.
25. Diswall, M., Gustafsson, A., Holgersson, J., Sandrin, M. S., and Breimer, M. E. 2011. Antigen-binding specificity of anti-alphaGal reagents determined by solid-phase glycolipid-binding assays. A complete lack of alphaGal glycolipid reactivity in alpha1,3GalT-KO pig small intestine. Xenotransplantation, 18, 28-39.
26. Ekser, B., Rigotti, P., Gridelli, B., and Cooper, D.K. 2009. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol, 21, 87-92.
27. Galili, U. 1999. Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope. Subcell Biochem, 32, 1-23.
28. Galili, U., Anaraki, F., Thall, A., Hill-Black, C., and Radic, M. 1993. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood, 82, 2485-2493.
29. Galili, U., Basbaum, C. B., Shohet, S. B., Buehler, J., and Macher, B. A. 1987. Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J Biol Chem, 262, 4683-4688.
30. Galili, U., Clark, M. R., Shohet, S. B., Buehler, J., and Macher, B. A. 1987. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates. Proc Natl Acad Sci USA, 84, 1369-1373.
31. Galili, U., LaTemple, D. C., and Radic, M. Z. 1998. A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation, 65, 1129-1132.
32. Galili, U., Rachmilewitz, E. A., Peleg, A., and Flechner, I. 1984. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med, 160, 1519-1531.
33. Galili, U., Shohet, S. B., Kobrin, E., Stults, C. L., and Macher, B. A. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem, 263, 17755-17762.
34. Galili, U. and Swanson, K. 1991. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA, 88, 7401-7404.
35. Galili, U., Tibell, A., Samuelsson, B., Rydberg, L., and Groth, C. G. 1995. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation, 59, 1549-1556.
36. Gastinel, L. N., Bignon, C., Misra, A. K. et al. 2001. Bovine alpha1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferases. EMBO J, 20, 638-649.
37. Gloor, J. M. and Stegall, M. D. 2007. ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens, 16, 529-534.
38. Gock, H., Salvaris, E., Murray-Segal, L. et al. 2000. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Xenotransplantation, 7, 237-246.
39. Good, A. H., Cooper, D. K. C., Malcolm, A. J. et al. 1992. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans. Transplant Proc, 24, 559-562.
40. Gronlund, H., Adedoyin, J., Commins, S. P., Platts-Mills, T. A., and van Hage, M. 2009. The carbohydrate galactose-alpha-1,3-galactose is a major IgE-binding epitope on cat IgA. J Allergy Clin Immunol, 123, 1189-1191.
41. Grunnet, N., Steffensen, R., Bennett, E. P., and Clausen, H. 1994. Evaluation of histo-blood group ABO genotyping in a Danish population: Frequency of a novel O allele defined as O2. Vox Sang, 67, 210-215.
42. Hakomori, S. 1999. Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer. Biochim Biophys Acta, 1473, 247-266.
43. Harnden, I., Kiernan, K., and Kearns-Jonker, M. 2010. The anti-nonGal xenoantibody response to alpha1,3-galactosyltransferase gene knockout pig xenografts. Curr Opin Organ Transplant, 15, 207-211.
44. Hisashi, Y., Yamada, K., Kuwaki, K. et al. 2008. Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant, 8, 2516-2526.
45. Hult, A. K., Yazer, M. H., Jorgensen, R. et al. 2010. Weak A phenotypes associated with novel ABO alleles carrying the A2-related 1061C deletion and various missense substitutions. Transfusion, 50, 1471-1486.
46. Ierino, F. L. and Sandrin, M. S. 2007. Spectrum of the early xenograft response: From hyperacute rejection to delayed xenograft injury. Crit Rev Immunol, 27, 153-166.
47. Jacquenet, S., Moneret-Vautrin, D. A., and Bihain, B. E. 2009. Mammalian meat-induced anaphylaxis: Clinical relevance of anti-galactose-alpha-1,3-galactose IgE confirmed by means of skin tests to cetuximab. J Allergy Clin Immunol, 124, 603-605.
48. Joziasse, D. H. 1992. Mammalian glycosyltransferases: Genomic organization and protein structure. Glycobiology, 2, 271-277.
49. Joziasse, D. H., Shaper, J. H., Jabs, E. W., and Shaper, N. L. 1991. Characterization of an alpha 1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem, 266, 6991-6998.
50. Joziasse, D. H., Shaper, J. H., Van den Eijnden, D. H., Van den Tunen, A. J., and Sharper, N. L. 1989. Bovine α1,3 galactosyltransferase: Isolation and characterisation of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem, 264, 14290-14297.
51. Joziasse, D. H., Shaper, N. L., Kim, D., Van den Eijnden, D. H., and Shaper, J. H. 1992. Murine α1,3 galactosyltransferase: A single gene locus specifies four isoforms of the enzyme by alternative spicing. J Biol Chem, 267, 5534-5541.
52. Kearns-Jonker, M., Barteneva, N., Mencel, R. et al. 2007. Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens. BMC Immunol, 8, 3.
53. Kearns-Jonker, M., Swensson, J., Ghiuzeli, C. et al. 1999. The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGHV3-74 IgVH germline progenitors. J Immunol, 163, 4399-4412.
54. Keusch, J. J., Manzella, S. M., Nyame, K. A., Cummings, R. D., and Baenziger, J. U. 2000. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem, 275, 25308-25314.
55. Koike, C., Friday, R. P., Nakashima, I. et al. 2000. Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene. Transplantation, 70, 1275-1283.
56. Konakci, K. Z., Bohle, B., Blumer, R. et al. 2005. Alpha-Gal on bioprostheses: Xenograft immune response in cardiac surgery. Eur J Clin Invest, 35, 17-23.
57. Kuwaki, K., Tseng, Y. L., Dor, F. J. et al. 2005. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med, 11, 29-31.
58. Lai, L., Kolber-Simonds, D., Park, K. W. et al. 2002. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science, 295, 1089-1092.
59. Landsteiner, K. 1962. The Specificity of Serological Reactions. New York: Dover Publications Inc.
60. Larsen, R. D., Rajan, V. P., Ruff, M. M. et al. 1989. Isolation of a cDNA encoding a murine UDPgalactose: beta-D-galactosyl-1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: Expression cloning by gene transfer. Proc Natl Acad Sci USA, 86, 8227-8231.
61. Lazarus, B. D., Milland, J., Ramsland, P. A., Mouhtouris, E., and Sandrin, M. S. 2002. Histidine 271 has a functional role in pig alpha-1,3galactosyltransferase enzyme activity. Glycobiology, 12, 793-802.
62. Mangold, A., Szerafin, T., Hoetzenecker, K. et al. 2009. Alpha-Gal specific IgG immune response after implantation of bioprostheses. Thorac Cardiovasc Surg, 57, 191-195.
63. McKenzie, I. F., Koulmanda, M., Mandel, T. E., and Sandrin, M. S. 1998. Pig islet xenografts are susceptible to “anti-pig” but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice. J Immunol, 161, 5116-5119.
64. McKenzie, I. F., Li, Y.Q., Patton, K., Thall, A. D., and Sandrin, M. S. 1998. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice. Transplantation, 66, 754-763.
65. Milland, J., Christiansen, D., Lazarus, B. D. et al. 2006. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol, 176, 2448-2454.
66. Milland, J., Christiansen, D., and Sandrin, M. S. 2005. Alpha1,3-galactosyltransferase knockout pigs are available for xenotransplantation: Are glycosyltransferases still relevant? Immunol Cell Biol, 83, 687-693.
67. Milland, J. and Sandrin, M. S. 2006. ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens, 68, 459-466.
68. Milland, J., Yuriev, E., Xing, P. X. et al. 2007. Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies. Immunol Cell Biol, 85, 623-632.
69. Mollison, P. E., Engelfreit, C. P., and Contreras, M. 1997. Blood Transfusion in Clinical Medicine. Oxford: Blackwell Science.
70. Nottle, M. B., Beebe, L. F., Harrison, S. J. et al. 2007. Production of homozygous alpha-1,3-galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation, 14, 339-344.
71. Nozawa, S., Xing, P. X., Wu, G. D. et al. 2001. Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse. Transplantation, 72, 147-155.
72. Nydegger, U., Mohacsi, P., Koestner, S. et al. 2005. ABO histo-blood group system-incompatible allografting. Int Immunopharmacol, 5, 147-153.
73. Ohdan, H., Swenson, K. G., Kruger Gray, H. S. et al. 2000. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J Immunol, 165, 5518-5529.
74. Park, C. S., Park, S. S., Choi, S. Y. et al. 2010. Anti alpha-gal immune response following porcine bioprosthesis implantation in children. J Heart Valve Dis, 19, 124-130.
75. Patenaude, S. I., Seto, N. O., Borisova, S. N. et al. 2002. The structural basis for specificity in human ABO(H) blood group biosynthesis. Nat Struct Biol, 9, 685-690.
76. Pearse, M. J., Witort, E., Mottram, P. et al. 1998. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: A model of delayed xenograft rejection. Transplantation, 66, 748-754.
77. Phelps, C. J., Koike, C., Vaught, T. D. et al. 2003. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science, 299, 411-414.
78. Porubsky, S., Speak, A. O., Luckow, B. et al. 2007. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci USA, 104, 5977-5982.
79. Puga Yung, G., Schneider, M. K., and Seebach, J.D. 2009. Immune responses to alpha1,3 galactosyltransferase knockout pigs. Curr Opin Organ Transplant, 14, 154-160.
80. Ramsland, P. A., Farrugia, W., Yuriev, E., Edmundson, A. B., and Sandrin, M. S. 2003. Evidence for structurally conserved recognition of the major carbohydrate xenoantigen by natural antibodies. Cell Mol Biol (Noisy-le-grand), 49, 307-317.
81. Salvaris, E., Gock, H., Han, W. et al. 2000. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection. Xenotransplantation, 7, 42-47.
82. Sandrin, M. S., Dabkowski, P. L., Henning, M. M., Mouhtouris, E., and McKenzie, I. F. C. 1994. Characterisation of cDNA clones for Porcine α(1,3)galactosyl transferase: The enzyme generating the Galα(1-3)Gal epitope. Xenotransplantation, 1, 81-88.
83. Sandrin, M. S. and McKenzie, I. F. C. 1994. Galα(1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev, 141, 169-190.
84. Sandrin, M. S., Vaughan, H. A., Dabkowski, P. L., and McKenzie, I. F. 1993. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA, 90, 11391-11395.
85. Sandrin, M. S., Vaughan, H. A., and McKenzie, I. F. C. 1994. Identification of Gal(α1-3)Gal as the major epitope for pig to human vascularised xenografts. Transplant Rev 8, 134-139.
86. Schumann, J., Mycko, M. P., Dellabona, P., Casorati, G., and MacDonald, H. R. 2006. Cutting edge: Influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands. J Immunol, 176, 2064-2068.
87. Scott-Browne, J. P., Matsuda, J. L., Mallevaey, T. et al. 2007. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol, 8, 1105-1113.
88. Sendai, Y., Sawada, T., Urakawa, M. et al. 2006. alpha1,3-Galactosyltransferase-gene knockout in cattle using a single targeting vector with loxP sequences and cre-expressing adenovirus. Transplantation, 81, 760-766.
89. Seto, N. O., Compston, C. A., Evans, S. V. et al. 1999. Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli. Eur J Biochem, 259, 770-775.
90. Seto, N. O., Compston, C. A., Szpacenko, A., and Palcic, M.M. 2000. Enzymatic synthesis of blood group A and B trisaccharide analogues. Carbohydr Res, 324, 161-169.
91. Seto, N. O., Palcic, M. M., Compston, C. A. et al. 1997. Sequential interchange of four amino acids from blood group B to blood group A glycosyltransferase boosts catalytic activity and progressively modifies substrate recognition in human recombinant enzymes. J Biol Chem, 272, 14133-14138.
92. Shaper, N. L., Lin, S. P., Joziasse, D. H., Kim, D. Y., and Yang-Feng, T. L. 1992. Assignment of two human alpha-1,3-galactosyltransferase gene sequences (GGTA1 and GGTA1P) to chromosomes 9q33-q34 and 12q14-q15. Genomics, 12, 613-615.
93. Sharma, A., Naziruddin, B., Cui, C. et al. 2003. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation, 75, 430-436.
94. Shimizu, A., Hisashi, Y., Kuwaki, K. et al. 2008. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol, 172, 1471-1481.
95. Slomiany, B. L., Slomiany, A., and Horowitz, M.I. 1974. Characterization of blood-group-H-active ceramide tetrasaccharide from hog-stomach mucosa. Eur J Biochem, 43, 161-165.
96. Speak, A. O., Salio, M., Neville, D. C. et al. 2007. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci USA, 104, 5971-5976.
97. Stone, K. R., Abdel-Motal, U. M., Walgenbach, A. W., Turek, T. J., and Galili, U. 2007. Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation, 83, 211-219.
98. Stussi, G., West, L., Cooper, D. K. and Seebach, J. D. 2006. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplantation, 13, 390-399.
99. Tanemura, M., Yin, D., Chong, A. S., and Galili, U. 2000. Differential immune responses to alpha-gal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation. J Clin Invest, 105, 301-310.
100. Taylor, S. G., McKenzie, I. F., and Sandrin, M. S. 2003. Characterization of the rat alpha(1,3)galactosyltransferase: Evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. Glycobiology, 13, 327-337.
101. Tearle, R. G., Tange, M. J., Zannettino, Z. L. et al. 1996. The a-1,3-galactosyltransferase knockout mouse: Implications for xenotransplantation. Transplantation, 61, 13-19.
102. Teneberg, S., Lonnroth, I., Torres Lopez, J. F. et al. 1996. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology, 6, 599-609.
103. Thall, A. D., Maly, P., and Lowe, J. B. 1995. Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem, 270, 21437-21440.
104. Tumbale, P., Jamaluddin, H., Thiyagarajan, N., Brew, K., and Acharya, K. R. 2008. Structural basis of UDP-galactose binding by alpha-1,3-galactosyltransferase (alpha3GT): Role of negative charge on aspartic acid 316 in structure and activity. Biochemistry, 47, 8711-8718.
105. Van Nunen, S. A., O’Connor, K. S., Clarke, L. R., Boyle, R. X., and Fernando, S. L. 2009. An association between tick bite reactions and red meat allergy in humans. Med J Aust, 190, 510-511.
106. Wei, D. G., Curran, S. A., Savage, P. B., Teyton, L., and Bendelac, A. 2006. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition. J Exp Med, 203, 1197-1207.
107. Wu, A., Buhler, L. H. and Cooper, D. K. 2003. ABO-incompatible organ and bone marrow transplantation: Current status. Transpl Int, 16, 291-299.
108. Xia, C., Yao, Q., Schumann, J. et al. 2006. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3). Bioorg Med Chem Lett, 16, 2195-2199.
109. Xu, H., Sharma, A., Chen, L. et al. 2001. The structure of anti-Gal immunoglobulin genes in naive and stimulated Gal knockout mice. Transplantation, 72, 1817-1825.
110. Yamada, K., Yazawa, K., Shimizu, A. et al. 2005. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med, 11, 32-34.
111. Yamamoto, F. 2004. Review: ABO blood group system-ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology, 20, 3-22.
112. Yamamoto, F., Clausen, H., White, T., Marken, J., and Hakomori, S. 1990. Molecular genetic basis of the histo-blood group ABO system. Nature, 345, 229-233.
113. Yamamoto, F. and Hakomori, S. 1990. Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J Biol Chem, 265, 19257-19262.
114. Yamamoto, F. and McNeill, P. D. 1996. Amino acid residue at codon 268 determines both activity and nucleotide-sugar donor substrate specificity of human histo-blood group A and B transferases. In vitro mutagenesis study. J Biol Chem, 271, 10515-10520.
115. Yamamoto, F., McNeill, P. D., and Hakomori, S. 1992. Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun, 187, 366-374.
116. Yamamoto, F., McNeill, P. D., and Hakomori, S. 1995. Genomic organization of human histo-blood group ABO genes. Glycobiology, 5, 51-58.
117. Yamamoto, F., McNeill, P. D., Kominato, Y. et al. 1993a. Molecular genetic analysis of the ABO blood group system: 2. cis-AB alleles. Vox Sang, 64, 120-123.
118. Yamamoto, F., McNeill, P. D., Yamamoto, M. et al. 1993b. Molecular genetic analysis of the ABO blood group system: 4. Another type of O allele. Vox Sang, 64, 175-178.
119. Yazer, M. H., Olsson, M. L., and Palcic, M. M. 2006. The cis-AB blood group phenotype: Fundamental lessons in glycobiology. Transfus Med Rev, 20, 207-217.
120. Yuriev, E., Agostino, M., Farrugia, W. et al. 2009. Structural biology of carbohydrate xenoantigens. Expert Opin Biol Ther, 9, 1017-1029.
121. Zhang, Y., Deshpande, A., Xie, Z. et al. 2004. Roles of active site tryptophans in substrate binding and catalysis by alpha-1,3 galactosyltransferase. Glycobiology, 14, 1295-1302.
122. Zhang, Y., Swaminathan, G. J., Deshpande, A. et al. 2003. Roles of individual enzyme-substrate interactions by alpha-1,3-galactosyltransferase in catalysis and specificity. Biochemistry, 42, 13512-13521.
123. Zhou, D., Mattner, J., Cantu, C., 3rd et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science, 306, 1786-1789.